Login to Your Account

Basilea: Ceftobiprole Custody in Post-EMA Divorce from J&J

By Cormac Sheridan

Wednesday, February 24, 2010
A ray of light recently pierced the gloom surrounding Basilea Pharmaceutica AG's program for its cephalosporin antibiotic ceftobiprole (Zevtera), which is in development for complicated skin and soft tissue infections. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription